What atypical antipsychotics, besides Seroquel (quetiapine), cause drowsiness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atypical Antipsychotics That Cause Drowsiness Besides Quetiapine

Olanzapine is the most sedating atypical antipsychotic besides quetiapine, followed by risperidone, with both medications commonly causing drowsiness as a significant side effect. 1, 2, 3

Sedation Profile of Atypical Antipsychotics

High Sedation Potential

  • Olanzapine: Causes significant drowsiness in approximately 53% of patients 3
    • Mechanism: Strong histamine H1 receptor and α1-adrenergic receptor antagonism
    • Sedation is often dose-dependent (10-20 mg range)
    • Particularly sedating when used in PTSD-related sleep disorders 1

Moderate Sedation Potential

  • Risperidone: Causes drowsiness in approximately 50% of patients 3, 4
    • Demonstrates significant α1-noradrenergic antagonism
    • Sedation typically occurs at doses of 1-3 mg/day
    • Often used in PTSD-related nightmares due to its sedative properties 1

Lower Sedation Potential

  • Aripiprazole: Causes less drowsiness compared to olanzapine and risperidone 4
  • Ziprasidone: Moderate somnolence profile 4
  • Lurasidone: Lower somnolence potential 4
  • Paliperidone: Lower somnolence potential 4

Clinical Considerations When Selecting Sedating Antipsychotics

Time Course of Sedation

  • Sedation is often most pronounced during initial treatment and may diminish over time
  • For olanzapine, drowsiness typically begins within hours of administration 2
  • For risperidone, sedation may be more pronounced with twice-daily dosing 5

Dosing Strategies to Manage Sedation

  1. Evening dosing: Administering more sedating antipsychotics at bedtime can utilize the sedative effect for sleep benefits
  2. Slow titration: Starting at lower doses and gradually increasing can help develop tolerance to sedative effects
  3. Once-daily dosing: When possible, consolidating doses to minimize daytime drowsiness

Risk Factors for Increased Sedation

  • Elderly patients
  • Concurrent use of other CNS depressants
  • Hepatic impairment (reduced drug metabolism)
  • Low body weight

Therapeutic Applications of Sedating Properties

Sedating antipsychotics can be beneficial in specific clinical scenarios:

  1. Agitation and acute psychosis: Sedation can be therapeutic in managing acute agitation 1
  2. PTSD-related nightmares: Olanzapine and risperidone have shown efficacy in reducing nightmares 1
  3. Insomnia with psychotic disorders: The sedative effect can help normalize sleep patterns

Adverse Effects Beyond Sedation

When selecting sedating antipsychotics, consider these additional adverse effects:

  • Olanzapine: Significant weight gain (51% of patients), metabolic effects 2, 3
  • Risperidone: Extrapyramidal symptoms (more common than with olanzapine), hyperprolactinemia 2, 1
  • All atypical antipsychotics: Risk of orthostatic hypotension, particularly during initial titration 6

Monitoring Recommendations

When using sedating antipsychotics:

  • Assess for excessive daytime drowsiness that may impact functioning
  • Monitor for falls, particularly in elderly patients 6
  • Evaluate the impact on driving and operating machinery
  • Consider dose adjustments if sedation is problematic after 4 weeks (when tolerance should develop) 4

Remember that sedation profiles can vary significantly between individuals, and clinical response should guide medication selection and dosing strategies.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Adverse events related to olanzapine.

The Journal of clinical psychiatry, 2000

Guideline

Risperidone Formulations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.